skip navigation nih record
Vol. LXV, No. 18
August 30, 2013

previous story

next story


NIDDK Alumnus Bieri Mourned

Dr. John Bieri

Dr. John Bieri, former NIDDK biochemist, died on July 30 at age 93.

From 1955 until his retirement in 1983, he served as head of the nutritional biochemistry section in the Laboratory of Nutrition and Endocrinology. His research focused on metabolism of vitamins A and E and essential fatty acids.

While at NIDDK, Bieri developed the NIH standard diet for laboratory rodents. Following retirement, he was a visiting lecturer at the University of Maryland and a consultant to industry. He was the recipient of the Public Health Service Superior Service Award and a fellow of the American Society for Nutrition.

Bieri is survived by his wife of 70 years, Shirley Bloch Bieri of Silver Spring, a son, 2 daughters, 4 grandchildren, 2 step-grandchildren and 2 great-grandchildren. He is also survived by 2 brothers.

Katz Named Director of NIAMS Branch

Dr. James D. Katz

Dr. James D. Katz has been named director of the Rheumatology Fellowship and Training Branch, NIAMS. He will oversee the Rheumatology Fellowship Training Program and direct the intramural Community Research and Care Branch.

Katz received his medical degree from Case Western Reserve University in 1986, and completed his internship and residency in internal medicine in 1989 at Western Pennsylvania Hospital. In 1991, he completed rheumatology fellowship training at the University of Connecticut Health Center. He is a fellow in the American College of Rheumatology and the American College of Physicians.

Most recently, Katz served as director of the division of rheumatology at George Washington University, where he led the Rheumatology Fellowship Program from 2001 to 2007. He published studies on decision-making skills in physician trainees and has received a number of honors and awards for his clinical expertise, teaching and mentoring.

Katz has also published papers in myositis, osteoarthritis and diagnostic imaging and pain management in rheumatology. He was recently appointed to the Food and Drug Administration’s arthritis advisory committee. In addition, he was selected as a rheumatology consultant to the White House medical unit.

back to top of page